You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Pulmonology
Eosinophils: A Biomarker in COPD
Learn how to identify chronic obstructive pulmonary disease (COPD) patients with type 2 inflammation using blood eosinophil (EOS) levels, understand the associated risks, and recognize factors that may influence EOS counts.
Learning objectives
- Describe the relationship between elevated blood EOS levels and negative outcomes in COPD, including increased exacerbation risk and lung function decline
- Explain the methodology for assessing blood EOS counts in COPD patients and recognize factors that may influence these counts in the clinical setting
- Explain the role of blood EOS in the Global Initiative for Chronic Obstructive Lung Disease management algorithm for exacerbation-prone patients
Description
This infographic highlights the role of blood EOS as a biomarker for type 2 inflammation in COPD, including their predictive value for exacerbation risk and lung function decline. It provides information on critical EOS cut-offs, the impact of elevated EOS levels, and factors influencing EOS counts in the clinical setting.
Tags
MAT-GLB-2502548 - 1.0 - 05/2025
Related resources
